Why are BIPOC patients less likely to stick with antidepressants? new study investigates
NCT ID NCT06799078
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores why Black, Indigenous, and People of Color (BIPOC) may have lower rates of starting and sticking with antidepressants after a one-time psychiatric consultation. Researchers will survey 60 adults diagnosed with depression to see if race affects whether they get recommended medication, start it, take the right dose, and stay on it. The goal is to understand barriers to fair treatment and inform better care strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward ways to reduce racial disparities in depression treatment, leading to more equitable care for BIPOC communities.
- What could go wrong
- This is an observational study with only 60 participants, so findings may not apply broadly. It does not test a new treatment, so direct patient benefits are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre for Addiction and Mental Health
Toronto, Ontario, M5S 2S1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who returns to work after stress treatment?
- Can a Parent-Targeted program ease Kids' behavior problems when depression is in the picture?
- A Two-Year watch: can brain scans and surveys predict depression and anxiety in teens?
- Can a Three-Session therapy rival CBT for Event-Related depression?
- Your genes could hold the key to better depression treatment
- A therapy that aims to boost wellbeing, not just ease symptoms — a trial puts it to the test